March 24, 2024 – March 30, 2024 – 5 Recalls (5 FDA, 0 USDA)

Current FDA & USDA Recall Trends


Recall / Contributing Factor(s)

  • 3/30/24 – Food & Beverage – mango bars in the variety pack – Potential to be contaminated with Salmonella.
    • “Finished product testing on the mango bars revealed that the finished product may contain Salmonella. The company has ceased distribution of the affected product. The company is conducting an investigation as to what caused the problem and will take effective action to prevent any future issue.” 1
  • 3/29/24 – Food & Beverage – Sushi products – Undeclared milk, wheat and eggs.
    • “Product is packaged in clear plastic packages with a Geisslers Supermarket Inc. label affixed to the top of the package. Type of sushi roll is listed below the Geisslers Supermarket Inc. emblem, and the UPC code is located on the bottom of the label, along with store location.” 2
  • 3/29/24 – Food & Beverage – All Purpose Flour – Undeclared milk and eggs.
    • “The recall was initiated after it was discovered by the firm that an equipment breakdown during production could have allowed allergen cross-contact.” 3
  • 3/28/24 – Drugs – Methocarbamol Injection, USP 1000 mg/10 mL (100mg/mL) (Single Dose Vial) – Device & Drug Safety – Presence of Particulate Matter.
    • FOR IMMEDIATE RELEASE –March 22, 2024– East Windsor, New Jersey, Eugia US LLC (f/k/a AuroMedics Pharma LLC) has initiated a voluntary recall of lot number 3MC23011 of Methocarbamol Injection, USP 1000 mg/10 mL (100mg/mL) (Single Dose Vial) – 10mL Vial to the consumer level due to a customer product complaint for the presence of white particles floating inside of the vial.” 4
  • 3/27/24 – Drugs – Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL – Super potent due to bottles being overfilled.
    • FOR IMMEDIATE RELEASE – March 27, 2024 – Amneal Pharmaceuticals, LLC. Bridgewater, New Jersey (Amneal), is voluntarily recalling 4 lots (see table below) of Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL packaged in 80 mL, 150 mL, or 300 mL pack sizes, to the Consumer Level. Some bottles may have been overfilled which can result in an over potent dosing regimen. The recommended maximum daily dose allowance for this product is up to 2gm/day and patients prescribed a dosing regimen of 500 mg/10mL would exceed this daily allowance, which may be harmful to patients with renal insufficiency. The error occurred during the manual bottle filling stage of manufacturing.” 5







Add Comment

Your email address will not be published. Required fields are marked *